A shortage of fresh water is one of the acute challenges facing the world today. An energy-efficient approach to converting sea water into fresh water could be of substantial benefit, but current desalination methods require high power consumption and operating costs or large-scale infrastructures, which make them difficult to implement in resource-limited settings or in disaster scenarios. Here, we report a process for converting sea water (salinity approximately 500 mM or approximately 30,000 mg l(-1)) to fresh water (salinity <10 mM or <600 mg l(-1)) in which a continuous stream of sea water is divided into desalted and concentrated streams by ion concentration polarization, a phenomenon that occurs when an ion current is passed through ion-selective membranes. During operation, both salts and larger particles (cells, viruses and microorganisms) are pushed away from the membrane (a nanochannel or nanoporous membrane), which significantly reduces the possibility of membrane fouling and salt accumulation, thus avoiding two problems that plague other membrane filtration methods. To implement this approach, a simple microfluidic device was fabricated and shown to be capable of continuous desalination of sea water (approximately 99% salt rejection at 50% recovery rate) at a power consumption of less than 3.5 Wh l(-1), which is comparable to current state-of-the-art systems. Rather than competing with larger desalination plants, the method could be used to make small- or medium-scale systems, with the possibility of battery-powered operation.
Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction 1 – 3 during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some patients experiencing prolonged symptoms, termed post-acute sequelae of SARS-CoV-2 (refs. 4 , 5 ). However, the burden of infection outside the respiratory tract and time to viral clearance are not well characterized, particularly in the brain 3 , 6 – 14 . Here we carried out complete autopsies on 44 patients who died with COVID-19, with extensive sampling of the central nervous system in 11 of these patients, to map and quantify the distribution, replication and cell-type specificity of SARS-CoV-2 across the human body, including the brain, from acute infection to more than seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, predominantly among patients who died with severe COVID-19, and that virus replication is present in multiple respiratory and non-respiratory tissues, including the brain, early in infection. Further, we detected persistent SARS-CoV-2 RNA in multiple anatomic sites, including throughout the brain, as late as 230 days following symptom onset in one case. Despite extensive distribution of SARS-CoV-2 RNA throughout the body, we observed little evidence of inflammation or direct viral cytopathology outside the respiratory tract. Our data indicate that in some patients SARS-CoV-2 can cause systemic infection and persist in the body for months.
In this paper, we introduce a simple, straight microchannel design for a nanofluidic protein concentration device. Compared with concentration devices previously developed, the anode channel and cathode channel in this new concentration scheme are both integrated into a straight microchannel, with one inlet and one outlet. Most of the functions of a conventional two-channel concentration device can be achieved by this concentration device, and the efficiency of sample accumulation can be controlled by the dimension of the Nafion membrane. Also, the operating mechanism of this device was tested on various material combinations such as PDMS (polydimethylsiloxane) channel-glass substrate and silicon channel-PDMS substrate. Using a combined PDMSsilicon device which was sealed reversibly without plasma bonding, surface based immunoassay for concentrator-enhanced detection of clinically relevant samples such as C-reactive protein (CRP) was demonstrated. As a result, it was possible to enhance the detection sensitivity of the immunoassay by more than 500 folds compared to the immunoassay without preconcentration process.
A sessile drop oscillates when an ac voltage is applied in electrowetting. The oscillation results from the time-varying electrical force concentrated on the three-phase contact line. Little is known about the feature of drop oscillation in electrowetting. In the present work, the drop oscillations are observed systematically, and a theoretical model is developed to analyze the oscillation. It is revealed that resonance occurs at certain frequencies and the oscillation pattern is significantly dependent on the applied ac frequencies. The domain perturbation method is used to derive the shape-mode equations under the assumptions of a weak viscous effect and small drop deformation. The electrical force concentrated on the three-phase contact line is approximated as a delta function, which is decomposed and substituted into each shape-mode equation as a forcing term. The theoretical results for the shape and frequency responses are compared with experimental results, which shows qualitative agreement.
COVID-19 is known to cause multi-organ dysfunction1-3 in acute infection, with prolonged symptoms experienced by some patients, termed Post-Acute Sequelae of SARS-CoV-2 (PASC)4-5. However, the burden of infection outside the respiratory tract and time to viral clearance is not well characterized, particularly in the brain3,6-14. We performed complete autopsies on 44 patients with COVID-19 to map and quantify SARS-CoV-2 distribution, replication, and cell-type specificity across the human body, including brain, from acute infection through over seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, even among patients who died with asymptomatic to mild COVID-19, and that virus replication is present in multiple extrapulmonary tissues early in infection. Further, we detected SARS-CoV-2 RNA in multiple anatomic sites, including regions throughout the brain, for up to 230 days following symptom onset. Despite extensive distribution of SARS-CoV-2 in the body, we observed a paucity of inflammation or direct viral cytopathology outside of the lungs. Our data prove that SARS-CoV-2 causes systemic infection and can persist in the body for months.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.